Home > Insider Trading > Filing (0001192482-18-000106)

Filing Details

Accession Number:: 0001192482-18-000106
Form Type:: 4/A
Zero Holdings:: No
Publication Time:: 2018-03-13 15:01:15
Reporting Period:: 2017-12-08

Accepted Time:: 2018-03-13 15:01:15
Original Submission Date:: 2017-12-12
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1651561	Tabula Rasa Healthcare Inc.	TRHC	()	4/A

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1125761	J Michael Gausling	205 Webster Street Bethlehem PA 18015		No	No	No	Yes

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Disposition	2017-12-08	523,085	$25.85	1,390,273	No	4	S	Indirect	By: Originate Growth Fund #1Q, L.P.
Common Stock	Disposition	2017-12-11	160,375	$25.85	1,229,898	No	4	S	Indirect	By: Originate Growth Fund #1Q, L.P.
Common Stock	Disposition	2017-12-08	237,195	$25.85	629,594	No	4	S	Indirect	By: Originate Growth Fund #1A, L.P.
Common Stock	Disposition	2017-12-11	72,625	$25.85	556,969	No	4	S	Indirect	By: Originate Growth Fund #1A, L.P.

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	S	Indirect	By: Originate Growth Fund #1Q, L.P.
No	4	S	Indirect	By: Originate Growth Fund #1Q, L.P.
No	4	S	Indirect	By: Originate Growth Fund #1A, L.P.
No	4	S	Indirect	By: Originate Growth Fund #1A, L.P.

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Common Stock	8,000	Direct

Footnotes

Represents shares of the Company's common stock sold by Originate Growth Fund #1Q, L.P. in an underwritten public offering completed on December 8, 2017 at a price per share of $25.85, after deducting underwriting discounts and commissions of $1.65 per share.
Represents shares of the Company's common stock sold by Originate Growth Fund #1Q, L.P. upon the exercise of the underwriters' over-allotment option in an underwritten public offering completed on December 11, 2017 at a price per share of $25.85, after deducting underwriting discounts and commissions of $1.65 per share.
Represents shares of the Company's common stock sold by Originate Growth Fund #1A, L.P. in an underwritten public offering completed on December 8, 2017 at a price per share of $25.85, after deducting underwriting discounts and commissions of $1.65 per share.
Represents shares of the Company's common stock sold by Originate Growth Fund #1A, L.P. upon the exercise of the underwriters' over-allotment option in an underwritten public offering completed on December 11, 2017 at a price per share of $25.85, after deducting underwriting discounts and commissions of $1.65 per share.
The general partner of Originate Growth Fund #1Q, L.P. and Originate Growth Fund #1A, L.P. is Originate Growth GP, LLC. The members of Originate Growth GP, LLC are Glen R. Bressner, Eric R. Arnson and Michael J. Gausling. The members of Originate Growth GP, LLC share voting and dispositive power over the shares held by Originate Growth Fund #1Q, L.P. and Originate Growth Fund #1A, L.P. Mr. Gausling disclaims beneficial ownership of such shares, except to the extent of his pecuniary interest. In addition, 5,565 shares granted to Mr. Bressner in September 2016 and 2,596 shares granted to Mr. Bressner in June 2017 are beneficially owned by Originate Growth Fund #1Q, L.P. and Originate Growth Fund #1A, L.P., with the shares allocated to each fund on a pro rata basis.